NovaBridge Biosciences (NBP) Share-based Compensation (2019 - 2026)

NovaBridge Biosciences (NBP) has reported Share-based Compensation for 5 consecutive years, with $3.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Share-based Compensation rose 378.76% year-over-year to $3.9 million; the TTM figure through Dec 2025 stood at $6.2 million (changed 0.13% YoY), while the FY2025 annual figure was $22.8 million, up 660.0% from the prior year.
• Share-based Compensation retreated to $3.9 million in Q4 2025 per NBP's latest filing, from $25.3 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $25.3 million in Q3 2025 and bottomed at $318000.0 in Q3 2024.
• Historically, Share-based Compensation has averaged $6.3 million across 3 years, with a median of $2.9 million in 2023.
• Annual changes were most pronounced in 2024 — Share-based Compensation sank 93.48% — and 2025, when it surged 7855.97%.
• NovaBridge Biosciences' Share-based Compensation stood at $12.6 million in 2023, then tumbled by 93.48% to $824000.0 in 2024, then soared by 378.76% to $3.9 million in 2025.
• Business Quant data shows NBP's Share-based Compensation at $3.9 million in Q4 2025, $25.3 million in Q3 2025, and $1.9 million in Q2 2025.